Skip to main content
SK Inc. logo

SK Inc. — Investor Relations & Filings

Ticker · 034730 ISIN · KR7034730002 KO Financial and insurance activities
Filings indexed 1,386 across all filing types
Latest filing 2025-03-07 Proxy Solicitation & In…
Country KR South Korea
Listing KO 034730

SK Inc. is the strategic investment holding company for SK Group, focused on enhancing corporate value through active portfolio management and strategic investments. The company concentrates on four core growth areas: advanced materials, biopharmaceuticals, green technologies, and digital. In advanced materials, it develops products such as SiC power semiconductors. Its biopharmaceutical operations function as a global Contract Development and Manufacturing Organization (CDMO), specializing in cell and gene therapies (CGT) and active pharmaceutical ingredients (APIs). The green technology portfolio includes investments in clean energy, hydrogen, and sustainable food alternatives. In the digital sector, SK Inc. invests in innovative technologies and future mobility solutions, continually rebalancing its portfolio to foster sustainable growth.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for SK. It outlines the meeting date, location, and the agenda items (보고안건 and 부의안건), which include financial statement approval, director appointments, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2025-03-07 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from SK regarding a 'Cash/In-kind Dividend Decision' (현금ㆍ현물 배당 결정). It details the dividend amount per share, total dividend amount, and updates regarding the dividend record date and shareholder meeting date. This falls under the category of dividend announcements.
2025-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for SK Inc., detailing the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and voting procedures. This document is a formal proxy statement and meeting notice sent to shareholders to solicit their participation and votes for the upcoming AGM. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category, as it contains the necessary information and materials for shareholders to exercise their voting rights.
2025-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement), which is a standard regulatory filing in Korea used by companies to request shareholder votes for an upcoming Annual General Meeting (AGM). It includes details on the meeting date, agenda items (financial statements, director appointments, etc.), and proxy solicitation procedures. While it contains financial data, it is a proxy solicitation document rather than an Annual Report (10-K) or an Earnings Release (ER). Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-03-07 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal regulatory filing from SK regarding the decision on cash and in-kind dividends. It specifies the dividend amount per share, the dividend record date, and the date of the general meeting of shareholders. This falls directly under the definition of a dividend announcement.
2025-03-07 Korean
특수관계인에대한출자
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from SK Inc. regarding an investment in a related party (SK Signet Inc.) via a third-party capital increase (paid-in capital increase). It details the investment amount, purpose, board approval date, and specific terms of the transaction. This type of disclosure regarding capital allocation and investment in subsidiaries or related entities falls under general regulatory filings as it does not fit into specific categories like M&A (which usually implies control changes or mergers) or share buybacks. Given the nature of the disclosure, it is classified as a Regulatory Filing (RNS).
2025-03-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.